Study is an important step forward in researchers’ understanding of treating damaged hearts with cell therapies.
Medicine by Design’s Pivotal Experiment Fund invests $1 million in four research teams to bridge the “valley of death” funding gap
Funding gives cutting-edge regenerative medicine concepts impacting heart disease, lung transplantation, degenerative brain disease and end-stage liver disease a pathway to clinical translation.
Medicine by Design-funded research team says the new treatment approach is not far from clinical trials. This is one of the ways Medicine by Design is transforming human health.